About MedX Health
MedX Health Corp, is listed on the Toronto TSX Venture Exchange (‘TSXV:MDX’).
Proudly Canadian, MedX develops and produces the software and hardware driving the world’s first FDA-approved Teledermatology platform; as well as the most trusted brand in Photobiomodulation Lasers. The MedX platform allows rapid, non-invasive imaging of skin lesions, which are securely transmitted to dermatologists for assessment within a period of 72 hours or less. MedX is headquartered in Toronto.
We Exist To Save Lives.
Our Executive Medical Board is headed by Dr. Trevor Champagne (Canada) and includes Dr. Paul Cohen (Canada) and Dr. Dan Siegel (USA).
Average wait time to see Dermatologists in:
What Our Clients Say
With MedX's optimised referral system, our highly accurate assessments and complete patient pathway has a proven catch rate of ~11% suspicious moles in 72hours or less.
Join the 200,000+ images already transforming care with MedX. Discover how our platform and patient pathways can deliver peace of mind to the worried well and escalations for those with suspicious lesions.
Get in touch today to see MedX in action.